EPISODE · Nov 17, 2025 · 2 MIN
ACT Brief: Smarter Study Planning, New AML Approval, and Biomarker Gaps in Cancer Care
from Applied Clinical Trials · host Applied Clinical Trials
In today’s ACT Brief, we look at how real-world data and AI are helping prevent costly study rescue, review the FDA’s approval of a first-in-class menin inhibitor for NPM1-mutated AML, and explore new insights on closing biomarker-testing gaps in oncology.
Embed this episode
Ready to play
ACT Brief: Smarter Study Planning, New AML Approval, and Biomarker Gaps in Cancer Care
0:00
2:17
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Applied Clinical Trials?
This episode is 2 minutes long.
When was this Applied Clinical Trials episode published?
This episode was published on November 17, 2025.
Can I download this Applied Clinical Trials episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!